{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "Hsiao_et_al.__2023_",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": true,
    "additional_count": 1
  },
  "completeness_stats": {
    "existing_evidence": 1,
    "new_evidence_found": 1,
    "total_evidence": 2
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "The Flublok Quadrivalent influenza vaccine (RIV4, Sanofi) is manufactured without chicken eggs, resulting in a recombinant hemagglutinin protein that is genetically identical to that in the selected strain.",
      "relevance_explanation": "This quote explicitly states that Flublok is manufactured using a recombinant process to produce hemagglutinin protein, and that it does not use chicken eggs, which is a key feature of the baculovirus expression vector system (BEVS) in insect cells."
    },
    {
      "id": "comp_1",
      "quote": "In traditional quadrivalent standard dose inactivated influenza vaccines (SD-IIV4), chicken eggs are used to manufacture the vaccine strain. The Flublok Quadrivalent influenza vaccine (RIV4, Sanofi) is manufactured without chicken eggs, resulting in a recombinant hemagglutinin protein that is genetically identical to that in the selected strain.",
      "relevance_explanation": "This quote explicitly contrasts the traditional egg-based production method with the recombinant approach used for Flublok, and states that Flublok results in a recombinant hemagglutinin protein, directly supporting the claim about its novel production platform.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}